Societe dEtude, de Recherche et de Fabrication
13
5
7
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
7.7%
1 terminated/withdrawn out of 13 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
80%
4 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Prospective and Obsevational Study of Total Hip Prothesis: HYPE Stem
Role: lead
Assessment of Safety and Performances of HYPE Stems Associated to a SERF Acetabular Cup in Hip Arthroplasty (2017-01-NH)
Role: lead
Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
Role: lead
Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison
Role: lead
Ambispective Multicentric Study Evaluating UKA With U-Knee/Uni-Kroma Implants
Role: lead
Hip Prospective Study
Role: lead
Clinical Performance of XPEO-E Liner in SERF Dual-mobility Cups
Role: lead
Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems
Role: lead
Ambispective, Multicentre, Open-label Study Evaluating the Clinical Outcomes of Foot Surgery Using SERF Medical Devices
Role: lead
Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties
Role: lead
Observational Ambispective Study on HYPE Cups Associated With HIPER Liner
Role: lead
Prospective Observational Study for the Evaluation of VEOFIX Varisation Staples
Role: lead
Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem
Role: lead
All 13 trials loaded